The DOI matches its Crossref record; 111 of the 111 references it cites were found in a registry or an index.
Diagnosis and Treatment of Clostridium difficile in Adults: A Systematic Review
Open accessAbstract
IMPORTANCE: Since 2000, the incidence and severity of Clostridium difficile infection (CDI) have increased. OBJECTIVE: To review current evidence regarding best practices for the diagnosis and treatment of CDI in adults (age ≥ 18 years). EVIDENCE REVIEW: Ovid MEDLINE and Cochrane databases were searched using keywords relevant to the diagnosis and treatment of CDI in adults. Articles published between January 1978 and October 31, 2014, were selected for inclusion based on targeted keyword searches, manual review of bibliographies, and whether the article was a guideline, systematic review, or meta-analysis published within the past 10 years. Of 4682 articles initially identified, 196 were selected for full review. Of these, the most pertinent 116 articles were included. Clinical trials, large observational studies, and more recently published articles were prioritized in the selection process. FINDINGS: Laboratory testing cannot distinguish between asymptomatic colonization and symptomatic infection with C difficile. Diagnostic approaches are complex due to the availability of multiple testing strategies. Multistep algorithms using polymerase chain reaction (PCR) for the toxin gene(s) or single-step PCR on liquid stool samples have the best test performance characteristics (for multistep: sensitivity was 0.68-1.00 and specificity was 0.92-1.00; and for single step: sensitivity was 0.86-0.92 and specificity was 0.94-0.97). Vancomycin and metronidazole are first-line therapies for most patients, although treatment failures have been associated with metronidazole in severe or complicated cases of CDI. Recent data demonstrate clinical success rates of 66.3% for metronidazole vs 78.5% for vancomycin for severe CDI. Newer therapies show promising results, including fidaxomicin (similar clinical cure rates to vancomycin, with lower recurrence rates for fidaxomicin, 15.4% vs vancomycin, 25.3%; P = .005) and fecal microbiota transplantation (response rates of 83%-94% for recurrent CDI). CONCLUSIONS AND RELEVANCE: Diagnostic testing for CDI should be performed only in symptomatic patients. Treatment strategies should be based on disease severity, history of prior CDI, and the individual patient's risk of recurrence. Vancomycin is the treatment of choice for severe or complicated CDI, with or without adjunctive therapies. Metronidazole is appropriate for mild disease. Fidaxomicin is a therapeutic option for patients with recurrent CDI or a high risk of recurrence. Fecal microbiota transplantation is associated with symptom resolution of recurrent CDI but its role in primary and severe CDI is not established.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Duodenal Infusion of Donor Feces for Recurrent Clostridium difficile
van Nood, E., Vrieze, A., Nieuwdorp, M., Fuentes, S., Zoetendal, E. G., de Vos, W. M., Visser, C. E., Kuijper, E. J., Bartelsman, J. F. W. M., Tijssen, J. G. P., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1205037 · Cited by 3,708
Cohen, S. H., Gerding, D. N., Johnson, S., Kelly, C. P., Loo, V. G., McDonald, L. C., Pepin, J., & Wilcox, M. H. (2010) · Infection Control & Hospital Epidemiology · doi:10.1086/651706 · Cited by 2,942
Zimlichman, E., Henderson, D., Tamir, O., Franz, C., Song, P., Yamin, C. K., Keohane, C., Denham, C. R., & Bates, D. W. (2013) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.9763 · Cited by 1,847
Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections
Surawicz, C. M., Brandt, L. J., Binion, D. G., Ananthakrishnan, A. N., Curry, S. R., Gilligan, P. H., McFarland, L. V., Mellow, M., & Zuckerbraun, B. S. (2013) · American Journal of Gastroenterology · doi:10.1038/ajg.2013.4 · Cited by 1,645
Fidaxomicin versus Vancomycin for Clostridium difficile Infection
Louie, T. J., Miller, M. A., Mullane, K. M., Weiss, K., Lentnek, A., Golan, Y., Gorbach, S., Sears, P., & Shue, Y.-K. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa0910812 · Cited by 1,585
Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia
Bartlett, J. G., Chang, T. W., Gurwith, M., Gorbach, S. L., & Onderdonk, A. B. (1978) · New England Journal of Medicine · doi:10.1056/nejm197803092981003 · Cited by 1,374
Kelly, C. P., Pothoulakis, C., & LaMont, J. T. (1994) · New England Journal of Medicine · doi:10.1056/nejm199401273300406 · Cited by 1,321
Zar, F. A., Bakkanagari, S. R., Moorthi, K. M. L. S. T., & Davis, M. B. (2007) · Clinical Infectious Diseases · doi:10.1086/519265 · Cited by 1,252
Debast, S. B., Bauer, M. P., & Kuijper, E. J. (2014) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12418 · Cited by 1,215
Pepin, J. (2004) · Canadian Medical Association Journal · doi:10.1503/cmaj.1041104 · Cited by 1,128
Rinttila, T., Kassinen, A., Malinen, E., Krogius, L., & Palva, A. (2004) · Journal of Applied Microbiology · doi:10.1111/j.1365-2672.2004.02409.x · Cited by 1,017
Treating Clostridium difficile infection with fecal microbiota transplantation
Bakken, J. S., Borody, T., Brandt, L. J., Brill, J. V., Demarco, D. C., Franzos, M. A., Kelly, C., Khoruts, A., Louie, T., Martinelli, L. P., et al. (2011) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2011.08.014 · Cited by 1,003
Gough, E., Shaikh, H., & Manges, A. R. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir632 · Cited by 1,003
Asymptomatic Carriage of Clostridium difficile and Serum Levels of IgG Antibody against Toxin A
Kyne, L., Warny, M., Qamar, A., & Kelly, C. P. (2000) · New England Journal of Medicine · doi:10.1056/nejm200002103420604 · Cited by 935
Kassam, Z., Lee, C. H., Yuan, Y., & Hunt, R. H. (2013) · American Journal of Gastroenterology · doi:10.1038/ajg.2013.59 · Cited by 904
Newberry, S. J. (2012) · JAMA · doi:10.1001/jama.2012.3507 · Cited by 870
Kyne, L., Warny, M., Qamar, A., & Kelly, C. P. (2001) · The Lancet · doi:10.1016/s0140-6736(00)03592-3 · Cited by 804
Cornely, O. A., Crook, D. W., Esposito, R., Poirier, A., Somero, M. S., Weiss, K., Sears, P., & Gorbach, S. (2012) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(11)70374-7 · Cited by 761
Treatment with Monoclonal Antibodies against Clostridium difficile Toxins
Lowy, I., Molrine, D. C., Leav, B. A., Blair, B. M., Baxter, R., Gerding, D. N., Nichol, G., Thomas, W. D., Leney, M., Sloan, S., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907635 · Cited by 746
Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children
Goldenberg, J. Z., Ma, S. S., Saxton, J. D., Martzen, M. R., Vandvik, P. O., Thorlund, K., Guyatt, G. H., & Johnston, B. C. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006095.pub3 · Cited by 741
Petrof, E. O., Gloor, G. B., Vanner, S. J., Weese, S. J., Carter, D., Daigneault, M. C., Brown, E. M., Schroeter, K., & Allen-Vercoe, E. (2013) · Microbiome · doi:10.1186/2049-2618-1-3 · Cited by 731
Breaking The Cycle: Treatment Strategies for 163 Cases of Recurrent Clostridium Difficile Disease
McFarland, L. V., Elmer, G. W., & Surawicz, C. M. (2002) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2002.05839.x · Cited by 724
Youngster, I., Russell, G. H., Pindar, C., Ziv-Baran, T., Sauk, J., & Hohmann, E. L. (2014) · JAMA · doi:10.1001/jama.2014.13875 · Cited by 629
Antimicrobial‐Associated Risk Factors for Clostridium difficile Infection
Owens, Jr., Donskey, C. J., Gaynes, R. P., Loo, V. G., & Muto, C. A. (2008) · Clinical Infectious Diseases · doi:10.1086/521859 · Cited by 603
Slimings, C., & Riley, T. V. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt477 · Cited by 581
Increasing Risk of Relapse after Treatment of Clostridium difficile Colitis in Quebec, Canada
Pepin, J., Alary, M.-E., Valiquette, L., Raiche, E., Ruel, J., Fulop, K., Godin, D., & Bourassa, C. (2005) · Clinical Infectious Diseases · doi:10.1086/430315 · Cited by 570
Recommendations for Surveillance of Clostridium difficile–Associated Disease
McDonald, L. C., Coignard, B., Dubberke, E., Song, X., Horan, T., Kutty, P. K., & the Ad Hoc Clostridium difficile Surveillance Working Group (2007) · Infection Control & Hospital Epidemiology · doi:10.1086/511798 · Cited by 558
Riggs, M. M., Sethi, A. K., Zabarsky, T. F., Eckstein, E. C., Jump, R. L. P., & Donskey, C. J. (2007) · Clinical Infectious Diseases · doi:10.1086/521854 · Cited by 550
Johnson, S., Louie, T. J., Gerding, D. N., Cornely, O. A., Chasan-Taber, S., Fitts, D., Gelone, S. P., Broom, C., Davidson, D. M., & for the Polymer Alternative for CDI Treatment (PACT) investigators (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu313 · Cited by 527
Wenisch, C., Parschalk, B., Hasenhundl, M., Hirschl, A. M., & Graninger, W. (1996) · Clinical Infectious Diseases · doi:10.1093/clinids/22.5.813 · Cited by 505
BACTERIOTHERAPY FOR CHRONIC RELAPSING CLOSTRIDIUM DIFFICILE DIARRHOEA IN SIX PATIENTS
Tvede, M., & Rask-Madsen, J. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92749-9 · Cited by 491
HOPKINS, M. J., & MACFARLANE, G. T. (2002) · Journal of Medical Microbiology · doi:10.1099/0022-1317-51-5-448 · Cited by 472
Cumulative Antibiotic Exposures Over Time and the Risk of Clostridium difficile Infection
Stevens, V., Dumyati, G., Fine, L. S., Fisher, S. G., & van Wijngaarden, E. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir301 · Cited by 446
Planche, T. D., Davies, K. A., Coen, P. G., Finney, J. M., Monahan, I. M., Morris, K. A., O'Connor, L., Oakley, S. J., Pope, C. F., Wren, M. W., et al. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70200-7 · Cited by 435
Cammarota, G., Ianiro, G., & Gasbarrini, A. (2014) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000000046 · Cited by 428
Crobach, M. J. T., Dekkers, O. M., Wilcox, M. H., & Kuijper, E. J. (2009) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2009.03098.x · Cited by 413
Primary symptomless colonisation by Clostridium difficile and decreased risk of subsequent diarrhoea
Shim, J. K., Johnson, S., Samore, M. H., Bliss, D. Z., & Gerding, D. N. (1998) · The Lancet · doi:10.1016/s0140-6736(97)08062-8 · Cited by 391
McFarland, L. V., Surawicz, C. M., & Stamm, W. E. (1990) · Journal of Infectious Diseases · doi:10.1093/infdis/162.3.678 · Cited by 378
Meta-analysis to assess risk factors for recurrent Clostridium difficile infection
Garey, K. W., Sethi, S., Yadav, Y., & DuPont, H. L. (2008) · Journal of Hospital Infection · doi:10.1016/j.jhin.2008.08.012 · Cited by 376
Johnston, B. C., Ma, S. S. Y., Goldenberg, J. Z., Thorlund, K., Vandvik, P. O., Loeb, M., & Guyatt, G. H. (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-157-12-201212180-00563 · Cited by 367
(1992) · American Journal of Infection Control · doi:10.1016/s0196-6553(05)80130-0 · Cited by 363
Johnson, S., Homann, S. R., Bettin, K. M., Quick, J. N., Clabots, C. R., Peterson, L. R., & Gerding, D. N. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-4-297 · Cited by 355
Neal, M. D., Alverdy, J. C., Hall, D. E., Simmons, R. L., & Zuckerbraun, B. S. (2011) · Annals of Surgery · doi:10.1097/sla.0b013e31822ade48 · Cited by 341
Nosocomial Clostridium difficile colonisation and disease
Johnson, S., Clabots, C. R., Linn, F. V., Olson, M. M., Peterson, L. R., Gerding, D. N., Johnson, S., Linn, F. V., Peterson, L. R., & Gerding, D. N. (1990) · The Lancet · doi:10.1016/0140-6736(90)91605-a · Cited by 340
Olson, M. M., Shanholtzer, C. J., Lee, J. T., & Gerding, D. N. (1994) · Infection Control & Hospital Epidemiology · doi:10.1086/646934 · Cited by 339
Diagnosis of Clostridium difficile infection by toxin detection kits: a systematic review
Planche, T., Aghaizu, A., Holliman, R., Riley, P., Poloniecki, J., Breathnach, A., & Krishna, S. (2008) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(08)70233-0 · Cited by 334
Bolton, R. P., & Culshaw, M. A. (1986) · Gut · doi:10.1136/gut.27.10.1169 · Cited by 320
Louie, T. J., Cannon, K., Byrne, B., Emery, J., Ward, L., Eyben, M., & Krulicki, W. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis338 · Cited by 310
Antibiotics and hospital-acquired Clostridium difficile-associated diarrhoea: a systematic review
Thomas, C. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg254 · Cited by 305
Fekety, R., Silva, J., Kauffman, C., Buggy, B., & Gunner Deery, H. (1989) · The American Journal of Medicine · doi:10.1016/0002-9343(89)90223-4 · Cited by 293
Sethi, A. K., Al-Nassir, W. N., Nerandzic, M. M., Bobulsky, G. S., & Donskey, C. J. (2010) · Infection Control & Hospital Epidemiology · doi:10.1086/649016 · Cited by 289
Miller, M., Gravel, D., Mulvey, M., Taylor, G., Boyd, D., Simor, A., Gardam, M., McGeer, A., Hutchinson, J., Moore, D., et al. (2010) · Clinical Infectious Diseases · doi:10.1086/649213 · Cited by 278
Fulminant Clostridium difficile Colitis: Patterns of Care and Predictors of Mortality
Sailhamer, E. A. (2009) · Archives of Surgery · doi:10.1001/archsurg.2009.51 · Cited by 261
Clostridium difficile Colonization and Diarrhea at a Tertiary Care Hospital
Samore, M. H., DeGirolami, P. C., Tlucko, A., Lichtenberg, D. A., Melvin, Z. A., & Karchmer, A. W. (1994) · Clinical Infectious Diseases · doi:10.1093/clinids/18.2.181 · Cited by 251
Vardakas, K. Z., Polyzos, K. A., Patouni, K., Rafailidis, P. I., Samonis, G., & Falagas, M. E. (2012) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2012.01.004 · Cited by 250
Leav, B. A., Blair, B., Leney, M., Knauber, M., Reilly, C., Lowy, I., Gerding, D. N., Kelly, C. P., Katchar, K., Baxter, R., et al. (2010) · Vaccine · doi:10.1016/j.vaccine.2009.10.144 · Cited by 248
Mullane, K. M., Miller, M. A., Weiss, K., Lentnek, A., Golan, Y., Sears, P. S., Shue, Y.-K., Louie, T. J., & Gorbach, S. L. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir404 · Cited by 245
Approach to patients with multiple relapses of antibiotic-associated pseudomembranous colitis.
Tedesco, F. J., Gordon, D., & Fortson, W. C. (1985) · PubMed · Cited by 217
Clinical Risk Factors for Severe Clostridium difficile–associated Disease
Henrich, T. J., Krakower, D., Bitton, A., & Yokoe, D. S. (2009) · Emerging Infectious Diseases · doi:10.3201/eid1503.080312 · Cited by 215
Asha, N. J., Tompkins, D., & Wilcox, M. H. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.00165-06 · Cited by 194
Toxin A-negative, toxin B-positive Clostridium difficile
Drudy, D., Fanning, S., & Kyne, L. (2007) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2006.04.003 · Cited by 192
Garey, K. W., Ghantoji, S. S., Shah, D. N., Habib, M., Arora, V., Jiang, Z.-D., & DuPont, H. L. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr377 · Cited by 181
Pépin, J., Valiquette, L., Gagnon, S., Routhier, S., & Brazeau, I. (2007) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01539.x · Cited by 175
Brandt, L. J. (2013) · American Journal of Gastroenterology · doi:10.1038/ajg.2012.450 · Cited by 171
Privitera, G., Scarpellini, P., Ortisi, G., Nicastro, G., Nicolin, R., & de Lalla, F. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.1.208 · Cited by 162
Apisarnthanarak, A., Razavi, B., & Mundy, L. M. (2002) · Clinical Infectious Diseases · doi:10.1086/342334 · Cited by 161
Al‐Nassir, W. N., Sethi, A. K., Nerandzic, M. M., Bobulsky, G. S., Jump, R. L. P., & Donskey, C. J. (2008) · Clinical Infectious Diseases · doi:10.1086/588293 · Cited by 160
Miller, M. A., Louie, T., Mullane, K. M., Weiss, K., Lentnek, A. L., Golan, Y., Kean, Y., & Sears, P. (2013) · BMC Infectious Diseases · doi:10.1186/1471-2334-13-148 · Cited by 155
Figueroa, I., Johnson, S., Sambol, S. P., Goldstein, E. J. C., Citron, D. M., & Gerding, D. N. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis357 · Cited by 150
Deshpande, A., Pasupuleti, V., Rolston, D. D. K., Jain, A., Deshpande, N., Pant, C., & Hernández, A. V. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir505 · Cited by 146
Reveles, K. R., Lee, G. C., Boyd, N. K., & Frei, C. R. (2014) · American Journal of Infection Control · doi:10.1016/j.ajic.2014.06.011 · Cited by 145
Shetty, N., Wren, M. W. D., & COEN, P. G. (2010) · Journal of Hospital Infection · doi:10.1016/j.jhin.2010.07.024 · Cited by 139
Johnson, S., Schriever, C. A., Patel, U. C., Patel, T. C., Hecht, D. W., & Gerding, D. N. (2009) · Anaerobe · doi:10.1016/j.anaerobe.2009.08.004 · Cited by 122
Wilcox, M. H., & Howe, R. A. (1995) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/36.4.673 · Cited by 122
Factors Associated With Failure of Metronidazole in Clostridium difficile–associated Disease
Fernandez, A. A., Anand, G., & Friedenberg, F. K. (2004) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-200405000-00005 · Cited by 111
Laboratory Diagnosis of Clostridium difficile Infection
Tenover, F. C., Baron, E. J., Peterson, L. R., & Persing, D. H. (2011) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2011.06.001 · Cited by 110
Fulminant Clostridium difficile colitis
Adams, S. D., & Mercer, D. (2007) · Current Opinion in Critical Care · doi:10.1097/mcc.0b013e3282638879 · Cited by 110
Is Fidaxomicin Worth the Cost? An Economic Analysis
Bartsch, S. M., Umscheid, C. A., Fishman, N. O., & Lee, B. Y. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit346 · Cited by 108
Effects of Clostridium difficile Toxins on Epithelial Cell Barrier
Pothoulakis, C. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb05263.x · Cited by 103
Risk factors for the development of fulminant Clostridium difficile colitis
Greenstein, A. J., Byrn, J. C., Zhang, L. P., Swedish, K. A., Jahn, A. E., & Divino, C. M. (2008) · Surgery · doi:10.1016/j.surg.2007.12.008 · Cited by 99
Overcoming barriers to effective recognition and diagnosis of Clostridium difficile infection
Wilcox, M. H. (2012) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12057 · Cited by 96
Is colectomy for fulminant Clostridium difficile colitis life saving? A systematic review
Stewart, D. B., Hollenbeak, C. S., & Wilson, M. Z. (2013) · Colorectal Disease · doi:10.1111/codi.12134 · Cited by 93
Prediction Tools for Unfavourable Outcomes in Clostridium difficile Infection: A Systematic Review
Chakra, C. N. A., Pépin, J., & Valiquette, L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030258 · Cited by 88
Segarra‐Newnham, M. (2007) · Annals of Pharmacotherapy · doi:10.1345/aph.1k110 · Cited by 83
Norén, T., Alriksson, I., Andersson, J., Åkerlund, T., & Unemo, M. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.01824-10 · Cited by 82
Laboratory Diagnosis of Clostridium difficile Infections: There Is Light at the End of the Colon
Brecher, S. M., Novak-Weekley, S. M., & Nagy, E. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit424 · Cited by 82
Fecal microbiota transplantation for the treatment of Clostridium difficile infection
Rao, K. K., & Safdar, N. (2015) · Journal of Hospital Medicine · doi:10.1002/jhm.2449 · Cited by 81
Self-citationTreatment of recurrent Clostridium difficile infection: a systematic review
O’Horo, J. C., Jindai, K., Kunzer, B., & Safdar, N. (2013) · Infection · doi:10.1007/s15010-013-0496-x · Cited by 79
Does a rapid diagnosis of Clostridium difficile infection impact on quality of patient management?
Barbut, F., Surgers, L., Eckert, C., Visseaux, B., Cuingnet, M., Mesquita, C. T., Pradier, N., Thiriez, A., Aït‐Ammar, N., Aifaoui, A., et al. (2013) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12221 · Cited by 77
Vardakas, K. Z., Konstantelias, A. A., Loizidis, G., Rafailidis, P. I., & Falagas, M. E. (2012) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2012.07.010 · Cited by 76
O’Horo, J. C., Jones, A., Sternke, M., Harper, C., & Safdar, N. (2012) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2012.02.024 · Cited by 73
Tigecycline for the Treatment of Severe Clostridium difficile Infection
Larson, K. C., Belliveau, P., & Spooner, L. M. (2011) · Annals of Pharmacotherapy · doi:10.1345/aph.1q080 · Cited by 71
Systemic Absorption of Enteral Vancomycin in a Patient with Pseudomembranous Colitis
SPITZER, P. G., & ELIOPOULOS, G. M. (1984) · Annals of Internal Medicine · doi:10.7326/0003-4819-100-4-533 · Cited by 69
The role of immunoglobulin for the treatment of Clostridium difficile infection: a systematic review
O’Horo, J. C., & Safdar, N. (2009) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2008.11.012 · Cited by 68
DIARRHŒA AND PSEUDOMEMBRANOUS COLITIS AFTER GASTROINTESTINAL OPERATIONS
Keighley, M. R. B., Alexander-Williams, J., Arabi, Y., Youngs, D. J., Burdon, D. W., Shinagawa, N., Thompson, H., Bentley, S., & GEORGE, R. H. (1978) · The Lancet · doi:10.1016/s0140-6736(78)92151-7 · Cited by 67
The Systemic Inflammatory Response to Clostridium difficile Infection
Rao, K. K., Erb‐Downward, J. R., Walk, S. T., Micić, D., Falkowski, N. R., Santhosh, K., Mogle, J. A., Ring, C., Young, V. B., Huffnagle, G. B., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0092578 · Cited by 65
Self-citationToxic Metronidazole-Induced MRI Changes
Horlen, C. K., Seifert, C. F., & Malouf, C. S. (2000) · Annals of Pharmacotherapy · doi:10.1345/aph.10028 · Cited by 58
Musgrave, C. R., Bookstaver, P. B., Sutton, S. S., & Miller, A. D. (2011) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2011.03.017 · Cited by 57
Safdar, N., Barigala, R., Said, A., & McKinley, L. L. (2008) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/j.1365-2710.2008.00980.x · Cited by 56
Modena, S., Gollamudi, S., & Friedenberg, F. K. (2005) · Journal of Clinical Gastroenterology · doi:10.1097/01.mcg.0000190761.80615.0f · Cited by 52
Fulminant Clostridium difficile colitis
van der Wilden, G. M., Chang, Y., Cropano, C. M., Subramanian, M. P., Schipper, I. B., Yeh, D. D., King, D. R., de Moya, M. A., Fagenholz, P. J., & Velmahos, G. C. (2014) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/ta.0000000000000105 · Cited by 47
Parmar, S., Bhatt, V., Yang, J., Zhang, Q., & Schuster, M. K. (2013) · Journal of Oncology Pharmacy Practice · doi:10.1177/1078155213490004 · Cited by 45
Low Risk of Irritable Bowel Syndrome afterClostridium difficileInfection
Piche, T., Vanbiervliet, G., Girard-Pipau, F., Dainese, R., Hébuterne, X., Rampal, P., & Collins, S. M. (2007) · Canadian Journal of Gastroenterology · doi:10.1155/2007/262478 · Cited by 44
Bakken, J. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu429 · Cited by 44
Johnson, S., & Gerding, D. N. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis833 · Cited by 36
Probiotics for the Prevention and Treatment of Antibiotic-Associated Diarrhea
Hempel, S., Newberry, S. J., Maher, A. R., Wang, Z., Miles, J. N. V., Shanman, R., & Shekelle, P. (2012) · Cited by 33
Hu, M. Y., Maroo, S., Kyne, L., Cloud, J. W., Tummala, S., Katchar, K., Dreisbach, V. C., Noddin, L., & Kelly, C. P. (2008) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2008.06.024 · Cited by 31
Probiotics for the Prevention of Clostridium difficile–Associated Diarrhea
Johnston, B. C., Goldenberg, J. Z., & Guyatt, G. H. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-158-9-201305070-00019 · Cited by 24
Bublin, J. G., & Barton, T. L. (1994) · PubMed · Cited by 16
Garimella, P. S., Agarwal, R. K., & Katz, A. (2012) · Journal of Postgraduate Medicine · doi:10.4103/0022-3859.101392 · Cited by 14
Fecal Microbiota Transplantation forClostridium difficileInfection
Armstrong, M. J., Pathmakanthan, S., & Iqbal, T. H. (2015) · JAMA · doi:10.1001/jama.2014.18617 · Cited by 5
Cited by
Magro, F., Gionchetti, P., Eliakim, R., Ardizzone, S., Armuzzi, A., Barreiro-de Acosta, M., Burisch, J., Gecse, K. B., Hart, A. L., Hindryckx, P., et al. (2017) · Journal of Crohn's and Colitis · doi:10.1093/ecco-jcc/jjx008 · Cited by 1,910
An insight into gut microbiota and its functionalities
Adak, A., & Khan, M. R. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2943-4 · Cited by 1,485
Kang, D.-W., Adams, J. B., Gregory, A. C., Borody, T., Chittick, L., Fasano, A., Khoruts, A., Geis, E., Maldonado, J., McDonough-Means, S., et al. (2017) · Microbiome · doi:10.1186/s40168-016-0225-7 · Cited by 1,391
Blauwkamp, T. A., Thair, S., Rosen, M. J., Blair, L., Lindner, M. S., Vilfan, I. D., Kawli, T., Christians, F. C., Venkatasubrahmanyam, S., Wall, G. D., et al. (2019) · Nature Microbiology · doi:10.1038/s41564-018-0349-6 · Cited by 962
Long-term benefit of microbiota transfer therapy on autism symptoms and gut microbiota
Kang, D.-W., Adams, J. B., Coleman, D. M., Pollard, E. L., Maldonado, J., McDonough-Means, S., Caporaso, J. G., & Krajmalnik-Brown, R. (2019) · Scientific Reports · doi:10.1038/s41598-019-42183-0 · Cited by 749
Metadata
- Authors
- Bagdasarian, N., Rao, K., & Malani, P. N.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2015-01-27
- Volume
- 313
- Issue
- 4
- Pages
- 398
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2011542551
- Cited by
- 451
- References
- 111
- FWCI
- 49.87
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.